HLA-B27 polymorphism

Joint Bone Spine

Volumn 68, Issue 5, 2001, Pages 378-382

  Ball, Edward J ^a   Khan, Muhammad Asim ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Alleles; Ankylosing spondylitis; HLA B*2705; HLA B27; Polymorphism; Spondyloarthropathies; Subtypes

Indexed keywords

AMINO ACID; HLA B27 ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; REVIEW; SPONDYLOARTHROPATHY;

EID: 0034769308     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00294-9     Document Type: Review

References (44)

1. HLA-B27 and immunogenetics of spondyloarthropathies
2. Update: The twenty subtypes of HLA-B27
3. HLA-B27 and its subtypes in world populations
4. Nomenclature for factors of the HLA system, update October
5. Nomenclature for factors of the HLA system, update June 1999
6. Nomenclature for factors of the HLA system, update October/November 1999
7. Nomenclature for factors of the HLA system, update November 1998
8. HLA class I region sequences, 1998
9. The HLA dictionary 1999: A summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens
10. A novel HLA-B27 allele (B*2711) encoding an antigen reacting with both B27-and B40-specific antisera
11. An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity
12. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis
13. Functional characterization and exon 2-intron 2-exon 3 gene sequence of HLA-B*2712 as found in a British family
14. Complete coding sequence of HLA-B*2712: A serologic B27-negative antigen associated to Bw6
15. HLA-B*27 subtyping by PCR-RFLP in Spanish patients with ankylosing spondylitis
16. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis
17. The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708)
18. Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic gamma delta T cell clone
19. Novel polymorphism detected in exon 1 of HLA-B*2713
20. Ankylosing spondylitis in West Africans: Evidence for a non-HLA-B27 protective effect
21. HLA-B27, ankylosing spondylitis, and the spondyloarthropathies
22. A worldwide overview: The epidemiology of HLA-B27 and associated spondyloarthritides
23. HLA-B27 subtypes, disease susceptibility, and peptide binding specificity
24. The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy
25. Clinical features of spondyloarthropathy in Chinese and native Indonesians
26. Immunogenetics. HLA-B27 and spondylarthropathy
27. Seronegative spondyloarthropathies and HLA-B27 subtypes: A study of Asian Indians
28. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy
29. Possible protective role of HLA-B*2706 for ankylosing spondylitis
30. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 allele
31. Evidence that HLA-B*2706 is not protective against spondyloarthropathy
32. HLA-B27 subtypes in Asian patients with ankylosing spondylitis: Evidence for new associations
33. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes
34. HLA-B27 polymorphism and association with disease
35. HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility
36. Identification of self peptides bound to purified HLA-B27
37. The three dimensional structure of HLA-B27 at 2.1. A resolution suggests a general mechanism for tight peptide binding to MHC
38. HLA-B27 (B*2701) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket
39. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis
40. Lack of carboxylterminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis
41. The HLA-B*2709 subtype in a patient with undifferentiated spondarthritis
42. HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes
43. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis